Bid publication date
Bid document is dated 07-08-2026.
- Bid Number: GEM/2026/B/7850470.
Loading
Loading…
Loading…
PROCUREMENT OF 18 ANTICANCER DRUGS FOR ECHS
Indian Navy · Ernakulam, Kerala9679424
Written by TenderKart AI from the documents published when it was generated. Check the tender for later corrigenda before you bid.
7 Aug 2026
24 Aug 2026
₹1.2 L
All important dates as they stand after corrigenda: publication, pre-bid/clarification deadline, bid submission deadline, bid opening, and bid validity period.
Bid document is dated 07-08-2026.
Bid End Date/Time is 17-08-2026 12:00:00.
Bid Opening Date/Time is 17-08-2026 12:30:00.
Bid Offer Validity is 180 days from the bid end date.
Time allowed for Technical Clarifications during technical evaluation is 2 Days.
Delivery period is 30 days for every schedule/item to the Ernakulam/Kochi consignee.
Tender value or estimated cost, EMD/bid security (amount, acceptable forms, validity), tender document fees, performance security, and key payment terms.
Estimated Bid Value is INR 1,21,000.78.
EMD is not required.
No tender fee is charged in this bid; GeM also treats asking for tender/bid participation fee as an invalid buyer ATC practice.
ePBG is 5.00% of contract value for 30 months; Advisory Bank is State Bank of India; beneficiary is The Commanding Officer, INHS Sanjivani.
For goods, 100% payment is released within 10 days of CRAC issue and online bill submission, subject to ePBG first being received and verified.
MSE purchase preference is enabled: eligible MSE OEMs within L1+15% may match L1 for 25% of bid quantity/amount.
Every pass/fail eligibility and qualification requirement: experience and past performance, turnover/net worth, registrations and certifications, consortium/JV rules, and debarment or blacklisting conditions.
Minimum average annual turnover of the bidder for 3 years is 0.5 Lakh(s).
OEM average turnover for last 3 years is 2 Lakh(s).
2 Year(s) of past experience is required for same/similar service/products.
Past Performance requirement is 20% of bid quantity in at least one of the last three Financial years.
MSE and Startup relaxations from Years of Experience and Turnover criteria are available (Complete).
Sellers must hold valid Drugs & Cosmetics Act manufacturing or authorized distributor licence, valid WHO-GMP, and give the listed regulatory/compliance undertakings.
Bidder must not be under liquidation, court receivership or similar proceedings, and must not be bankrupt; an undertaking is to be uploaded with the bid.
Any bidder from a country sharing a land border with India is eligible only if registered with the Competent Authority; false declaration is ground for immediate termination and legal action.
Quoted products must not be obsolete and must have at least 2 years residual market life (not declared end-of-life by OEM before that period).
What is being procured: the work, supplies or services, deliverables and quantities, locations, phases, completion or delivery timelines, applicable standards, and notable exclusions.
Supply of 18 BOQ items titled “PROCUREMENT OF 18 ANTICANCER DRUGS FOR ECHS”, total quantity 1087 units/packs, under item-wise evaluation.
All quantities are to be delivered within 30 days to INHS Sanjivani, Naval Base, Kochi-682004 (Ernakulam).
Drugs must comply with CDSCO norms and be IP/BP/USP only, with residual shelf-life and cold-chain requirements for sensitive items.
Purchaser may increase or decrease ordered quantity by up to 25% of bid quantity at placement, and increase up to 25% of contracted quantity during currency at contracted rates.
Two Packet Bid with item-wise evaluation; contract awarded schedule-wise with separate L1 for each schedule; Bid to RA enabled with H1 elimination.
The complete checklist of documents to submit — mandatory vs conditional, with any prescribed formats, proformas or annexures — plus how to submit: portal and mode, envelope/cover structure, digital signature requirements, signing and attestation rules, and physical originals with their deadline.
Bids are to be submitted online on GeM as a Two Packet Bid; no physical-document pre-requisite is imposed by the buyer.
GeM uses Aadhaar-based e-sign treated as at par with digital signatures under the IT Act Amendment 2008.
Every corrigendum/addendum in order — what changed (original vs amended value), its impact, and the action for the bidder — ending with the values that finally apply.
The tender document set contains no corrigendum or addendum; original bid values continue to apply.
Genuine conflicts within and across the documents (original vs corrigenda, clause vs annexure, tender document vs BOQ): both sides with citations, and which value prevails.
Title says procurement of 18 anticancer drugs, but BOQ includes non-anticancer drugs and devices.
Specification simultaneously states 75–80% residual shelf life, 5/6 residual shelf life, and 2/3 for imported items.
BOQ item 5 names a specific brand/model (COLOPLAST ALTERNA OSTOMY BAG 17001), while GeM disclaimer says mandating specific brand/make/model/manufacturer/dealer (except PAC/single bid) makes bid & contract null & void.
BOQ lists INJ FILGRASTIM 300MG and INJ SEMAGLUTIDE 0.5MCG, which conflict with commonly used strengths/units for these molecules and with the 1 MG Semaglutide line in the same BOQ.
Only critical, tender-specific pre-bid queries that could materially change bid/no-bid, pricing, eligibility or contractual risk. Skip generic or obvious questions the documents already answer clearly.
Ask buyer to confirm whether Filgrastim is 300 mcg (not 300 mg) and whether Semaglutide item 12 is 0.5 mg (not 0.5 mcg).
Seek clarification whether residual shelf life at supply is 75–80%, 5/6, or 2/3 for imported items, and how mixed packs are measured.
Clarify trigger, time limit, quantity basis, logistics cost bearer, and whether replacement obligation survives full payment/CRAC for drugs not consumed within DOE/shelf life.
Ask whether only COLOPLAST ALTERNA 17001 is acceptable or equivalent ostomy bags meeting clinical specs will be considered.
Confirm whether drain bag and ostomy bag require the same drug manufacturing/WHO-GMP pack as medicines, or alternate device quality docs.
Clarify whether bidders must quote all 18 schedules, or may bid selected schedules, and whether post-award short/partial quantity delivery is barred.
Commercial, legal and execution risks a bidder should weigh: liquidated damages and penalties, unusual or one-sided clauses, tight timelines, and payment or security risks.
All items have only 30 delivery days, and buyer ATC says delivery period will not be extended without valid justification approved by CFA (Commanding Officer).
Mandatory undertaking to replace drugs not consumed within shelf life (DOE) creates potentially uncapped post-supply commercial exposure.
High residual shelf-life requirement plus stability data/cold-chain for injectables increase sourcing cost and rejection risk.
Successful seller must furnish 5% ePBG for 30 months despite 30-day delivery, and payment is due only after ePBG receipt/verification.
Option clause allows quantity decrease/increase up to 25% at placement and further increase up to 25% during currency at contracted rates.
Consignee may reject within 10 days of receipt; no payment for rejected goods; failure to lift rejected goods can lead to disposal at seller’s risk and cost.
Bid sets Arbitration Clause and Mediation Clause as No; GTC says dispute method follows options selected by buyer in the bid.
Documents uploaded by bidders (including clarification/representation docs) are displayed to other participating bidders after login.
The inviting authority and relevant contacts: office, person, designation, address, phone and email — and which address receives physical submissions, if any.
Ministry of Defence — Department of Military Affairs — Indian Navy; procurement for ECHS medical stores via INHS Sanjivani.
HOD email: [email protected]; Buyer email: [email protected].
The Commanding Officer, INHS Sanjivani, Naval Base, Kochi-682004 is the delivery address and ePBG/EMD beneficiary office.
Specification for BOQ bidding is signed by Rini Mathews, Surg Commander, Dy Oi/C ECHS Medical Stores, for Commanding Officer.